期刊文献+

高效液相色谱-质谱联用法测定大鼠血浆中柚皮素及其葡萄糖醛酸结合物的血药浓度 被引量:3

Determination of Naringenin and Its Glucuronic Acid Conjugate in Rat Plasma by LC-MS /MS
原文传递
导出
摘要 目的建立柚皮素血浆浓度的高效液相色谱-串联质谱(HPLC-MS/MS)分析方法,研究柚皮素及其葡萄糖醛酸结合物在大鼠体内的药动学。方法色谱柱为Shimpack ODS C18柱(2.3 mm×75 mm,3μm),流动相为体积比0.1%醋酸水溶液和甲醇,梯度洗脱,流速0.2 mL·min-1,MRM负离子模式扫描,定量离子对为m/z 271.1→151.0(柚皮素),301.2→164.1(橙皮素,内标)。结果柚皮素血浆加标样品在10 ng·mL-1~4μg·mL-1内线性关系良好(r=0.999 7),高、中、低浓度回收率均在85%~115%之间。采用该方法系统研究了灌胃给药时不同给药剂量下大鼠的柚皮素及其葡萄糖醛酸结合物的血药浓度情况。结论所建方法快速,灵敏,重现性好。柚皮素在血中达峰较快,且大部分与血液中的葡萄糖醛酸结合,少部分以游离形式存在。 OBJECTIVE To establish an LC-MS /MS method for determination of naringenin and its glucuronic acid conjugate in rat plasma. METHODS A Shimpack ODS C18column( 2. 3 mm × 75 mm,3 μm) was used with a mobile phase consisting of 0. 1% acetic acid solution and methanol at the flow rate of 0. 2 mL·min- 1. The detection mode was MRM,and the precursor / product ion pair was m / z 271. 1→151. 0 for naringenin and m / z 301. 2→164. 1 for the IS. RESULTS The calibration curve was linear in the range of 0. 01- 4 μg·mL- 1( r =0. 999 7) for naringenin. The average recoveries at high,medium,and low concentrations were between 85%- 115%. The method was used to determine the plasma concentration of naringenin after gastric gavages of different dosages to Wister rats. CONCLUSION The method is rapid,sensitive and reproducible. Naringenin,reaching peak concentration quickly, has low concentration in plasma and most became its glucuronic acid conjugate.
作者 张婷婷 马辰
出处 《中国药学杂志》 CAS CSCD 北大核心 2014年第10期864-868,共5页 Chinese Pharmaceutical Journal
基金 "重大新药创制"国家科技重大专项(2012ZX09301002-001-006)
关键词 柚皮素 高效液相色谱-质谱联用法 血药浓度 葡萄糖醛酸结合物 naringenin HPLC-MS /MS plasma concentration glucuronic acid conjugate
  • 相关文献

参考文献1

二级参考文献8

共引文献5

同被引文献57

  • 1唐黎黎,杨运周,傅佳,李光武.柚皮素对大鼠局灶性脑缺血再灌注损伤的保护作用[J].安徽医科大学学报,2006,41(4):430-432. 被引量:21
  • 2周大勇,徐青,薛兴亚,章飞芳,梁鑫淼.高效液相色谱-电喷雾质谱法测定枳壳中黄酮苷类化合物[J].分析化学,2006,34(U09):31-35. 被引量:43
  • 3陈雪峰,刘迪,李欣.超临界CO_2萃取桃叶中柚皮素的工艺研究[J].食品科学,2007,28(1):106-109. 被引量:15
  • 4李瑞芳,左学兰,周颖,何莉,陈飞.柚皮素对人髓系白血病K562细胞增殖的作用[J].武汉大学学报(医学版),2007,28(3):344-347. 被引量:11
  • 5MIR IA, TIKU AB. Chemopreventive and therapeutic potential of "naringenin," a flavanone present in citrus fruits [ J ]. Nutr Cancer, 2015, 67(1): 27 -42.
  • 6PATEL K, SINGH GK, PATEL DK. A review on pharmacological and analytical aspects of naringenin[ J ]. Chin J lntegr Med, 2014, Dec 10, Epub ahead of print, DOI: 10. 1007/s11655- 014-1960-x.
  • 7ORHAN IE, NABAV1 SF, DAGLIA M, et al. Naringening and atherosclerosis: a review of literature[ J]. Curr Pharm Biotechn- ol, 2015, 16(3): 245 -251.
  • 8ZHANG Y, WANG JF, DONG J, et al. Inhibition of a-toxin production by suhinhibitory concentrations of naringenin controls Staphylococcus aureus pneumonia [ J ]. Fitoterapia, 2013, 86 (4) : 92 -99.
  • 9CHEN Y, NIE YC, LUO YL, et al. Protective effects of naringin against paraquat-induced acute lung injury and pulmonary fibrosis in mice[J]. Food Chem Toxicol, 2013, 58(8) : 133 -144.
  • 10CHEN Y, WU H, NIE YC, et al, Mucoactive effects of naringin in lipopolysaccharide-induced acute lung injury mice and beagle dogs[J]. Environ Toxicol Pharmacol, 2014, 38 ( 1 ) : 279 - 287.

引证文献3

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部